Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher on Thursday. The clinical-stage biopharmaceutical company seems to be benefitting from wider excitement in the obesity treatment area, as well as recent positive momentum after major clinical trial developments. VKTX stock is…
Eli Lilly and Company (NYSE:LLY) shares are in the spotlight following reports indicating the company is close to finalizing a White House agreement to provide its lowest-dose obesity medications at $149 per month, which could open the door to Medicare…
Johnson & Johnson (NYSE:JNJ) is reportedly in discussions to acquire Protagonist Therapeutics (NASDAQ:PTGX). Citing people close to the talks, the Wall Street Journal reported that the deal is not guaranteed, and the terms have yet to be finalized. Year to…
Opendoor Technologies Inc (NASDAQ:OPEN) shares are falling on Monday after hedge fund manager George Noble posted on X that the company is “total garbage,” raising concerns about the stock’s recent rally. What Happened: Noble, who has founded two billion-dollar hedge…
Market speculation is mounting on a potential tie-up between QuantumScape Corp. (NYSE:QS) and Tesla, Inc. (NASDAQ:TSLA). While no official announcement has been made, there are some notable links between the battery maker and the EV giant. Here's a look at…
Corteva Inc. (NYSE:CTVA) is reportedly considering a major restructuring that would split its seed and pesticide operations into two separate entities. The pure-play agriculture company, valued at roughly $50 billion, could announce its plans soon if negotiations stay on track.…
New On The Block Siemens Healthineers is chatting with major private equity firms about a potential sale of its diagnostics business. According to Bloomberg, Blackstone, CVC, KKR, and Montagu are interested. The segment is valued at over €6 billion ($7…
Private equity firm Thoma Bravo is reportedly in talks to acquire Dayforce Inc. (NASDAQ:DAY). Dayforce, formerly Ceridian, which offers human resources software and services. The company has a market value of approximately $8.4 billion, according to data from Benzinga Pro.…
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday. Shares of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) fell sharply in today’s pre-market trading after the company reported the Phase 3 ADVANCE-2 trial evaluating…
Monday, Acadia Pharmaceuticals Inc (NASDAQ:ACAD) released top-line results from the Phase 3 ADVANCE-2 trial evaluating pimavanserin for negative symptoms of schizophrenia. Pimavanserin did not demonstrate a statistically significant improvement over placebo on the study’s primary endpoint, the change from baseline to week 26…